On Monday, the Maharashtra Food and Drug Administration (FDA) issued an urgent appeal for the citizens to immediately stop the sale or use of a specific batch of Coldrif syrup, following reports of child deaths in Madhya Pradesh and Rajasthan, news agency PTI reported.

Earlier, the Tamil Nadu drug control authorities, in their report dated October 2, declared the Coldrif syrup sample (Batch No. SR-13; Manufactured: May 2025; Expiry: April 2027), produced by Sresan Pharmaceuticals, Kancheepuram, as adulterated owing to the presence of 48.6 per cent of diethylene glycol, a toxic substance "which may render the contents injurious to health."